These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 28052584)

  • 1. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
    Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
    Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of flow cytometric HIT assays in relation to an IgG-Specific immunoassay and clinical outcome.
    Kerényi A; Beke Debreceni I; Oláh Z; Ilonczai P; Bereczky Z; Nagy B; Muszbek L; Kappelmayer J
    Cytometry B Clin Cytom; 2017 Sep; 92(5):389-397. PubMed ID: 26860978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis.
    Ramacciotti E; Hawley AE; Farris DM; Ballard NE; Wrobleski SK; Myers DD; Henke PK; Wakefield TW
    Thromb Haemost; 2009 Apr; 101(4):748-54. PubMed ID: 19350121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased blood cell phosphatidylserine exposure and circulating microparticles contribute to procoagulant activity after carotid artery stenting.
    Zhao L; Wu X; Si Y; Yao Z; Dong Z; Novakovic VA; Guo L; Tong D; Chen H; Bi Y; Kou J; Shi H; Tian Y; Hu S; Zhou J; Shi J
    J Neurosurg; 2017 Nov; 127(5):1041-1054. PubMed ID: 28009236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
    Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
    Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microparticle formation after exposure of blood to activated endothelium under flow.
    Macey MG; Wolf SI; Lawson C
    Cytometry A; 2010 Aug; 77(8):761-8. PubMed ID: 20653016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein apheresis reduces platelet factor 4 on the surface of platelets: a possible protective mechanism against heparin-induced thrombocytopenia and thrombosis.
    Tanhehco YC; Rux AH; Sachais BS
    Transfusion; 2011 May; 51(5):1022-9. PubMed ID: 20977482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI.
    Kasthuri RS; Glover SL; Jonas W; McEachron T; Pawlinski R; Arepally GM; Key NS; Mackman N
    Blood; 2012 May; 119(22):5285-93. PubMed ID: 22394597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
    Prechel MM; Jeske WP; Walenga JM
    Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of erythrocytes and platelets in the hypercoagulable status in polycythemia vera through phosphatidylserine exposure and microparticle generation.
    Tan X; Shi J; Fu Y; Gao C; Yang X; Li J; Wang W; Hou J; Li H; Zhou J
    Thromb Haemost; 2013 Jun; 109(6):1025-32. PubMed ID: 23571603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet Activation in Heparin-Induced Thrombocytopenia is Followed by Platelet Death via Complex Apoptotic and Non-Apoptotic Pathways.
    Mordakhanova ER; Nevzorova TA; Synbulatova GE; Rauova L; Weisel JW; Litvinov RI
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32272655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
    Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
    Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of phosphatidylserine-positive platelets and leukocytes and microparticles to hypercoagulable state in gastric cancer patients.
    Yang C; Ma R; Jiang T; Cao M; Zhao L; Bi Y; Kou J; Shi J; Zou X
    Tumour Biol; 2016 Jun; 37(6):7881-91. PubMed ID: 26700666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.
    Sellam J; Proulle V; Jüngel A; Ittah M; Miceli Richard C; Gottenberg JE; Toti F; Benessiano J; Gay S; Freyssinet JM; Mariette X
    Arthritis Res Ther; 2009; 11(5):R156. PubMed ID: 19832990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo.
    Mezouar S; Darbousset R; Dignat-George F; Panicot-Dubois L; Dubois C
    Int J Cancer; 2015 Jan; 136(2):462-75. PubMed ID: 24889539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo.
    Thomas GM; Panicot-Dubois L; Lacroix R; Dignat-George F; Lombardo D; Dubois C
    J Exp Med; 2009 Aug; 206(9):1913-27. PubMed ID: 19667060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Knowledge about Molecular Mechanisms of Heparin-Induced Thrombocytopenia Type II and Treatment Targets.
    Mongirdienė A; Liuizė A; Kašauskas A
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of microparticles in whole blood by multicolour flow cytometry assay.
    Christersson C; Johnell M; Siegbahn A
    Scand J Clin Lab Invest; 2013 Apr; 73(3):229-39. PubMed ID: 23452203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.